NL7206434A - - Google Patents

Info

Publication number
NL7206434A
NL7206434A NL7206434A NL7206434A NL7206434A NL 7206434 A NL7206434 A NL 7206434A NL 7206434 A NL7206434 A NL 7206434A NL 7206434 A NL7206434 A NL 7206434A NL 7206434 A NL7206434 A NL 7206434A
Authority
NL
Netherlands
Application number
NL7206434A
Other versions
NL170564B (nl
NL170564C (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7206434A publication Critical patent/NL7206434A/xx
Publication of NL170564B publication Critical patent/NL170564B/xx
Application granted granted Critical
Publication of NL170564C publication Critical patent/NL170564C/xx

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948Sedatives, e.g. cannabinoids, barbiturates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/535Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/946CNS-stimulants, e.g. cocaine, amphetamines
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486Analgesics, e.g. opiates, aspirine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NLAANVRAGE7206434,A 1971-05-14 1972-05-12 Werkwijze voor immunochemische bepaling van liganden. NL170564C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14360971A 1971-05-14 1971-05-14

Publications (3)

Publication Number Publication Date
NL7206434A true NL7206434A (enrdf_load_stackoverflow) 1972-11-16
NL170564B NL170564B (nl) 1982-06-16
NL170564C NL170564C (nl) 1982-11-16

Family

ID=22504809

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7206434,A NL170564C (nl) 1971-05-14 1972-05-12 Werkwijze voor immunochemische bepaling van liganden.

Country Status (12)

Country Link
JP (1) JPS5327763B1 (enrdf_load_stackoverflow)
BR (1) BR7202989D0 (enrdf_load_stackoverflow)
CA (1) CA1003770A (enrdf_load_stackoverflow)
CH (1) CH553410A (enrdf_load_stackoverflow)
DE (1) DE2223385C3 (enrdf_load_stackoverflow)
ES (1) ES402720A1 (enrdf_load_stackoverflow)
FR (1) FR2139505A5 (enrdf_load_stackoverflow)
GB (2) GB1401298A (enrdf_load_stackoverflow)
IL (1) IL39323A (enrdf_load_stackoverflow)
IT (1) IT972332B (enrdf_load_stackoverflow)
NL (1) NL170564C (enrdf_load_stackoverflow)
SE (1) SE403190B (enrdf_load_stackoverflow)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1028643A (en) * 1975-02-20 1978-03-28 Judith I. Blakemore Polylodothyronine immunoassay
US4104367A (en) * 1976-10-13 1978-08-01 Hoffmann-La Roche Inc. Radioimmunoassay for methadone
US4220450A (en) * 1978-04-05 1980-09-02 Syva Company Chemically induced fluorescence immunoassay
DE2923139A1 (de) * 1979-06-07 1980-12-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von immunologisch aktiven enzymmarkierten konjugaten
JPS56501583A (enrdf_load_stackoverflow) * 1979-11-19 1981-10-29
EP0095286B1 (en) * 1982-05-26 1985-12-18 Boots-Celltech Diagnostics Limited Immunoassay
GB8407736D0 (en) * 1984-03-26 1984-05-02 Univ London Detecting specific polynucleotide sequences
IT1178788B (it) * 1984-12-21 1987-09-16 Sclavo Spa Metodo immunoenzimatico per la determinazione di analiti e composizione adatti allo scopo
US4833073A (en) * 1987-01-27 1989-05-23 Hoffmann-La Roche Inc. Immunoassay for tetrahydrocannabinol metabolites
US5137804A (en) * 1988-05-10 1992-08-11 E. I. Du Pont De Nemours And Company Assay device and immunoassay
US5374524A (en) * 1988-05-10 1994-12-20 E. I. Du Pont De Nemours And Company Solution sandwich hybridization, capture and detection of amplified nucleic acids
US5196306A (en) * 1989-03-29 1993-03-23 E. I. Du Pont De Nemours And Company Method for the detection or quantitation of an analyte using an analyte dependent enzyme activation system
EP2418492B1 (en) * 2010-08-10 2018-10-10 Randox Laboratories Ltd. Immunoreagent for meprobamate

Also Published As

Publication number Publication date
CA1003770A (en) 1977-01-18
DE2223385B2 (de) 1979-02-22
CH553410A (fr) 1974-08-30
JPS5327763B1 (enrdf_load_stackoverflow) 1978-08-10
FR2139505A5 (enrdf_load_stackoverflow) 1973-01-05
BR7202989D0 (pt) 1973-11-01
DE2223385A1 (de) 1973-01-04
GB1401298A (en) 1975-07-16
SE403190B (sv) 1978-07-31
NL170564B (nl) 1982-06-16
DE2223385C3 (de) 1984-10-25
IL39323A (en) 1975-08-31
IL39323A0 (en) 1972-06-28
GB1401297A (en) 1975-07-16
NL170564C (nl) 1982-11-16
ES402720A1 (es) 1976-12-01
IT972332B (it) 1974-05-20

Similar Documents

Publication Publication Date Title
FR2139505A5 (enrdf_load_stackoverflow)
ATA136472A (enrdf_load_stackoverflow)
AR196074A1 (enrdf_load_stackoverflow)
AU2564071A (enrdf_load_stackoverflow)
AU2485671A (enrdf_load_stackoverflow)
AU2941471A (enrdf_load_stackoverflow)
AU2952271A (enrdf_load_stackoverflow)
AU3005371A (enrdf_load_stackoverflow)
AU2894671A (enrdf_load_stackoverflow)
AR202997Q (enrdf_load_stackoverflow)
AU2588771A (enrdf_load_stackoverflow)
AU2415871A (enrdf_load_stackoverflow)
AU2456871A (enrdf_load_stackoverflow)
AU2837671A (enrdf_load_stackoverflow)
AU2399971A (enrdf_load_stackoverflow)
AU2854371A (enrdf_load_stackoverflow)
AU1109576A (enrdf_load_stackoverflow)
AU2875571A (enrdf_load_stackoverflow)
AU2880771A (enrdf_load_stackoverflow)
AU2455871A (enrdf_load_stackoverflow)
AU2885171A (enrdf_load_stackoverflow)
AU2486471A (enrdf_load_stackoverflow)
AU2940971A (enrdf_load_stackoverflow)
AU2473671A (enrdf_load_stackoverflow)
AU2927871A (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
V4 Discontinued because of reaching the maximum lifetime of a patent